Clinical Trial Update: Interferon-α After DLI for the Prevention of Relapse [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study evaluating Interferon-α after donor lymphocyte infusion to prevent relapse in leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Interferon (interferon)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Leukemia | Phase 1, Phase 2 | Status: UNKNOWN